SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
芬达要加冰
Lv1
70 积分
2023-10-07 加入
最近求助
最近应助
互助留言
The Biosimilar Paradox: How Anti–Vascular Endothelial Growth Factor Biosimilars Could Increase Patient and Overall Health Care Costs
1天前
求助中
胆道恶性肿瘤转化治疗专家共识(2025)
3个月前
已完结
A Quadruplex Ultrasensitive Immunoassay for Simultaneous Assessment of Human Reproductive Hormone Proteins in Multiple Biofluid Samples
7个月前
已完结
Accurate and portable tumor exosomes detection based on manganese dioxide and aptamer-functionalized fluorescent microspheres mediated dual-mode lateral flow assay
7个月前
已完结
Feasibility and tolerability of sintilimab plus anlotinib as the second-line therapy for patients with advanced biliary tract cancers: An open-label, single-arm, phase II clinical trial
7个月前
已完结
Neutrophil membrane-coated immunomagnetic nanoparticles for efficient isolation and analysis of circulating tumor cells
8个月前
已完结
Real-World Clinical Outcomes of Bevacizumab-awwb Biosimilar versus Bevacizumab Reference Product in Patients with Metastatic Colorectal Cancer
9个月前
已完结
The comparison of safety and cost between reference drug of rituximab and its biosimilar Riximyo in lymphoproliferative disorders and other hematological diseases. Single center experience
10个月前
已完结
The comparison of safety and cost between reference drug of rituximab and its biosimilar Riximyo in lymphoproliferative disorders and other hematological diseases. Single center experience
10个月前
已关闭
A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity
10个月前
已完结
没有进行任何应助
我求助的是附件的参考文献,不需要文章正文
3个月前
感谢,点赞,速度真快
7个月前
点赞,帮大忙了,么么哒
7个月前
速度真快,帮大忙了,么么哒
8个月前
帮大忙了,么么哒
10个月前
不需要了,谢谢【积分已退回】
10个月前
速度真快,么么哒,感谢,点赞
10个月前
感谢,点赞,帮大忙了
11个月前
点赞,速度真快,帮大忙了
11个月前
非文章正文
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论